Systemic and local injections of lupeol inhibit tumor growth in a melanoma-bearing mouse model.

Melanoma is the most aggressive type of skin cancer and it is procured from activated or genetically altered epidermal melanocytes. In the present study, the tumor-suppressive effects of systemic and local injections of lupeol, a triterpene extracted from Indian lettuce (Lactuca indica), in a melanoma-bearing mouse model were evaluated. Mice were injected once with lupeol or olive oil (solvent control) subcutaneously into the skin of the back or into the tumor tissue. Seven days after the injection, the tumor growth rates were calculated and the tumor tissues were collected. Immunohistochemical staining for Ki-67 and proliferating cell nuclear antigen (PCNA) were performed. The tumor growth rates in the lupeol-injected group were significantly decreased compared to those observed in the non-treated (NT) and solvent control groups. Lupeol also significantly decreased the areas positively stained for Ki-67 and PCNA in the tumor tissues compared to those in the NT and solvent control groups. The results of the present study demonstrated that systemic and local injections of lupeol suppress tumor growth and induce cell cycle arrest in a melanoma-bearing mouse model. These data suggest that lupeol may be effective as a novel therapeutic option for melanoma patients.

[1]  Delong Liu,et al.  Current management and novel agents for malignant melanoma , 2012, Journal of Hematology & Oncology.

[2]  A. Hauschild,et al.  The Oncologist® Academia–Pharma Intersect: Melanoma , 2022 .

[3]  Mohammad Saleem,et al.  Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene. , 2009, Cancer letters.

[4]  M. Bracken,et al.  Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. , 2009, Journal of the National Cancer Institute.

[5]  K. Hata,et al.  Melanoma cell differentiation induced by lupeol separates into two stages: morphological and functional changes , 2009, Journal of Natural Medicines.

[6]  Yogeshwer Shukla,et al.  Lupeol: connotations for chemoprevention. , 2008, Cancer letters.

[7]  H. Mukhtar,et al.  Lupeol Inhibits Growth of Highly Aggressive Human Metastatic Melanoma Cells In vitro and In vivo by Inducing Apoptosis , 2008, Clinical Cancer Research.

[8]  Donna Niedzwiecki,et al.  Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  S. Jentsch,et al.  PCNA, the Maestro of the Replication Fork , 2007, Cell.

[10]  P. Bergman Canine oral melanoma. , 2007, Clinical techniques in small animal practice.

[11]  Yasuyuki Kosaka,et al.  Differentiation-inducing activity of lupane triterpenes on a mouse melanoma cell line , 2007, Cytotechnology.

[12]  Y. Shukla,et al.  Hepatoprotective effects of lupeol and mango pulp extract of carcinogen induced alteration in Swiss albino mice. , 2007, Molecular nutrition & food research.

[13]  V. Adhami,et al.  Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway. , 2005, Carcinogenesis.

[14]  J. Murata,et al.  Remodeling of actin cytoskeleton in lupeol-induced B16 2F2 cell differentiation. , 2005, Journal of biochemistry.

[15]  K. Hata,et al.  Role of p38 MAPK in lupeol-induced B16 2F2 mouse melanoma cell differentiation. , 2003, Journal of biochemistry.

[16]  K. Bae,et al.  Antiangiogenic activity of lupeol from Bombax ceiba , 2003, Phytotherapy research : PTR.

[17]  M. Heatley Epithelioid microgranulomas after Pentostatin therapy in hairy cell leukaemia , 2002, Histopathology.

[18]  K. Gatter,et al.  Ki67 protein: the immaculate deception? , 2002, Histopathology.

[19]  S. Dusza,et al.  Issues in the epidemiology of melanoma , 2001, Expert review of anticancer therapy.

[20]  P. Varalakshmi,et al.  Anti-inflammatory activity of lupeol and lupeol linoleate in rats. , 2001, Journal of ethnopharmacology.

[21]  T. Konishi,et al.  Differentiation-inducing activity of lupeol, a lupane-type triterpene from Chinese dandelion root (Hokouei-kon), on a mouse melanoma cell line. , 2000, Biological & pharmaceutical bulletin.

[22]  F. Lacombe,et al.  Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. , 1991, Cytometry.